Ramesh Poluru

Ramesh Poluru

Senior Program Officer 

The INCLEN Trust International, India

Email: ramesh.poluru@gmail.com

 

 

 

 

VALIDATE Role:

Network Associate

 

Research Keywords: 

Public Health, Clinical Trials, Demography

 

Biography:

Ramesh Poluru did his Masters and PhD in Population Studies from Sri Venkateswara University, Tirupati, India. His interests and expertise spans across demography, statistics, epidemiology, vaccine safety, impact assessment, public health and surveillance (reproductive and child health, STIs, HIV/AIDS).

Dr Poluru has more than two decades of experience in conceptualization, implementation and monitoring of large scale socioeconomic, demographic, behavioural, biological and operations research studies; analysis and interpretation of data (primary and secondary), using both qualitative and quantitative approaches. He has also extensively involved in the facility, community-based studies, action/operations research, phase-3 & 4 clinical trials, to deliver intervention services among general population (women and children) to more vulnerable populations (infants, minority population, high-risk groups-sex workers, MSM, IDU and truckers).

Dr Poluru has published about 40 research papers in peer-reviewed journals/chapters, and co-authored technical reports of national and international research projects.

 

Related Websites:

Twitter

 

Key Publications:

  • Mathur, A., Sinha, A.P., Raja, D., Gupta, Y.K., Kawade,A., Poluru, R., ; The ProSPoNS Trial Group. Compensation in neonatal clinical trials: A perspective. Indian Pediatrics, 2024; 61(4)
  • Garg, C.C., Mukhopadhyay, R., Arora, N.K., Awasthi, S., Verma, RK., Poluru, R., et al., Cost of treating sick young infants (0-59 days) with Possible Serious Bacterial Infection in resource-constrained outpatient primary care facilities: An insight from implementation research in two districts of Haryana and Uttar Pradesh (India), J Glob Health, 2023;13:04062.
  • Sinha, A.P., Bahuguna, P., Gupta, S.S., Kuruba, Y.P., Poluru, R., Mathur, A., Koppula, D.R., Raut, A.V., Mahajan, K., Sudhakar, R., Kulkarni,B., Pandey, R.M., Arora, N. K., Prinja, S., & the ProSPoNS Trial group of investigators. Study protocol for economic evaluation of probiotic intervention for prevention of neonatal sepsis in 0–2-month old low-birth weight infants in India: the ProSPoNS trial, BMJ Open. 2023 Mar 29;13(3):e068215. 
  • A. Sharan, A.L. Stuurman, S. Jahagirdar, V. Elango, M. Riera-Montes, N. Kashyap, J. Biccler, Poluru, R., Arora, N.K, et al., Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy, eClinicalMedicine 50, August 2022.
  • A.L. Stuurman, A. Sharan, S. Jahagirdar, V. Elango, M. Riera-Montes, N. Kashyap, J. Biccler, Poluru, R., Arora, N.K, et al., WHO Global Vaccine Safety Multi-Country Collaboration Project on safety in pregnancy: assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization, Vaccine: X (2021).
  • Mukhopadhyay R, Arora, N.K., Sharma, P.K., Dalpath, S., Limbu, P., Kataria, G., Singh, R.K., Poluru, R., et al., 2021, Lessons from an implementation research on community management of possible serious bacterial infection (PSBI) in young infants (0-59 days), when referral is not feasible in Palwal district of Haryana, India. PloS one, July, 2021.
  • Sinha, A.P., Gupta, S.S., Poluru, R., Raut, A.V., Arora, N.K., Pandey, R.M., et al., 2021, Evaluating the Efficacy of a Multistrain Probiotic Supplementation for Prevention of Neonatal Sepsis in 0-2 Months Old Low Birth Weight Infants in India – The ‘ProSPoNS’ Study Protocol for a Phase III, Multicentric, Randomized, Double-Blind, Placebo-Controlled Trial. Trials, 22, 242.
  • Das, M.K., Arora, N.K., Poluru, R., Tate, J.E., Gupta, B., Sharan, A., Aggarwal, M.K., Haldar, P., Parashar, U.D., Zuber, P.L. and Bonhoeffer, J., et al., INCLEN Intussusception Surveillance Network Study Group, 2021. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis, Vaccine, 39(1): 78-84.
  • Arora, N.K., Das, M.K., Poluru, R., Kashyap, N.K., Mathew, T., Mathai, J., Aggarwal, M.K., Haldar, P., Verstraeten, T., Zuber, P.L. and INCLEN Vaccine Safety Study Group, 2020. A Prospective Cohort study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Poliovirus Vaccines in two South Indian Districts, Pediatric Infectious Disease Journal, May; 39(5):389.
  • Poluru, R., 2008, Are social group differentials in fertility narrowing with rising levels of standard? Artha Vijnana, L (1): 21–43.